Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurora Fine Chemicals is a leading global provider of chemical compounds and contract research services for the pharmaceutical and biotechnology industries. Founded in 1990, the company maintains one of the world's largest collections of screening compounds, exceeding 6.8 million unique structures, along with a comprehensive catalog of building blocks and intermediates. They specialize in supporting early-stage drug discovery through the provision of diverse and target-focused chemical libraries, custom synthesis, and hit-to-lead optimization. With state-of-the-art facilities in San Diego, California, and Graz, Austria, the company serves as a critical partner for researchers in identifying and developing novel therapeutic agents. Their services are utilized by major pharmaceutical companies, emerging biotechs, and academic institutions worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurora Chemical.